Early-pregnancy multiple serum markers and second-trimester uterine artery doppler in predicting preeclampsia

Obstetrics and Gynecology

Volumn 115, Issue 6, 2010, Pages 1233-1238

  Thilaganathan, Basky ^a   Wormald, Ben ^a   Zanardini, Cristina ^a   Sheldon, Joanna ^a   Ralph, Elizabeth ^a   Papageorghiou, Aris T ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CYSTATIN C; NEOPTERIN; SERUM AMYLOID A;

ADULT; AREA UNDER THE CURVE; ARTERY BLOOD FLOW; ARTERY RESISTANCE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SECOND TRIMESTER PREGNANCY; UNIVARIATE ANALYSIS; UTERINE ARTERY;

ADULT; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYSTATIN C; FEMALE; HUMANS; NEOPTERIN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; ROC CURVE; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 77952963341     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181dd5137     Document Type: Article

References (30)

1. Papageorghiou AT. Predicting and preventing preeclampsia-where to next? Ultrasound Obstet Gynecol 2008;31:367-370
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799
3. Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM, Zavaleta N, et al. World health organization calcium supplementation for the prevention of preeclampsia. Am J Obstet Gynecol 2006;194:639-649
4. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson GA. ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006;354:1796-1806
5. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamins in preeclampsia (VIP) Trial Consortium. Lancet 2006;367: 1145-1154
6. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. PARIS Collaborative Group. Antiplatelet agents prevention for pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007;369:1791-1798
7. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000;96:559-564
8. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH. Fetal Medicine Foundation Second Trimester Screening Group. Multicenter screening for preeclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441-449 (Pubitemid 33078411)
9. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for preeclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:583-586 (Pubitemid 34063054)
10. Papageorghiou AT, Leslie K. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol 2007;19:103-109
11. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and pre-term preeclampsia. Ultrasound Obstet Gynecol 2008;32: 133-137
12. Aquilina J, Thompson O, Thilaganathan B, Harrington K. Improved early prediction of preeclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol 2001;17:477-484
13. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nico-laides KH. Prediction of preeclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22+0 to 24+6 weeks' gestation. Ultrasound Obstet Gynecol 2006;27:658-663
14. Prefumo F, Canini S, Casagrande V, Pastorino D, Venturini PL, De Biasio P. Correlation between first-trimester uterine artery Doppler indices and maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril 2006;86:977-980
15. CnossenJS, ter Riet G, Mol BW, van der PostJA, Leeflang MM, Meads CA, et al. Are tests for predicting preeclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand. 2009;88: 758-765
16. Prefumo F, Sebire NJ, Thilaganathan B. Decreased endovas-cular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum Reprod 2004;19:206-209
17. Lin S, Shimizu I, Suehara N, Nakayama M, Aono T. Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995;85(5 Pt 1):760-765
18. Aardema MW, Oosterhof H, Timmer A, van Rooy I, Aar-noudse JG Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by preeclampsia and small for gestational age fetuses. Placenta 2001;22:405-411
19. Kristensen K, Larsson I, Hansson SR. Increased cystatin C expression in the preeclamptic placenta. Mol Hum Reprod 2007;13:189-195
20. Kristensen K, Wide-Swensson D, Schmidt C, Blirup-Jensen S, Lindstrom V, Strevens H, et al. Cystatin C, beta-2-microglobulin and beta-trace protein in preeclampsia. Acta Obstet Gynecol Scand 2007;86:921-926
21. Thilaganathan B, Ralph E, Papageorghiou AT, Melchiorre K, Sheldon J. Raised maternal serum cystatin C: an early pregnancy marker for preeclampsia. Reprod Sci 2009;16: 788-793
22. Haddad B, Desvaux D, Livingston JC, Barranger E, Paniel BJ, Sibai BM. Failure of serum beta2-microglobulin levels as an early marker of preeclampsia. Am J Obstet Gynecol 2000;182: 595-598
23. Engin-Ustün Y, Ustün Y, Karabulut AB, Ozkaplan E, Mey-danli MM, Kafkasli A. Serum amyloid A levels are increased in preeclampsia. Gynecol Obstet Invest 2007;64:117-120
24. Kronborg CS, Knudsen UB, Moestrup SK, Allen J, Vittinghus E, Møller HJ. Serum markers of macrophage activation in preeclampsia: no predictive value of soluble CD163 and neopterin. Acta Obstet Gynecol Scand 2007;86:1041-1046
25. Kaleli I, Kaleli B, Demir M, Yildirim B, Cevahir N, Demir S. Serum Levels of Neopterin and Interleukin-2 Receptor in Women With Severe Preeclampsia. J Clin Lab Anal 2005;19: 36-39
26. Ustün Y, Engin-Ustün Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005;121:154-158
27. Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent preeclampsia. BJOG 2002;109:759-764
28. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertension 2004;17:154-160 (Pubitemid 38125133)
29. Tjoa ML, Van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003;59: 29-37.
30. Garcia RG, Celedon J, Sierra-Laquado J, Alarcon MA, Luen-gas C, Silva F, et al. Raised C-reactive protein and impaired flow-mediated vasodilatation precede the development of pre-eclampsia. Am J Hypert 2007;20:98-103.